Table of Contents
Volume 8 | Supplement 3
Publication Date: March 2008- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Contributions | ||
S94-S99 |
Treatment of Metastatic ErbB2-Positive Breast Cancer: Options After Progression on Trastuzumab Neil Spector |
|
S100-S113 |
Circumventing De Novo and Acquired Resistance to Trastuzumab: New Hope for the Care of ErbB2-Positive Breast Cancer Martine Piccart |
|
S114-S120 |
Cardiac Toxicity of ErbB2-Targeted Therapies: What Do We Know? Edith A. Perez |
|
S121-S130 |
Can We Circumvent Resistance To ErbB2-Targeted Agents By Targeting Novel Pathways? Mark Pegram |
|
S131-S141 |
Expert Roundtable: Emerging Questions in ErbB2-Positive Breast Cancer; February 22, 2007 Mark Pegram, Edith A. Perez, Martine Piccart, Neil Spector |
|